Samuel Thomas

519 total citations
11 papers, 421 citations indexed

About

Samuel Thomas is a scholar working on Infectious Diseases, Virology and Materials Chemistry. According to data from OpenAlex, Samuel Thomas has authored 11 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Virology and 4 papers in Materials Chemistry. Recurrent topics in Samuel Thomas's work include HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Graphite, nuclear technology, radiation studies (4 papers). Samuel Thomas is often cited by papers focused on HIV Research and Treatment (4 papers), HIV/AIDS drug development and treatment (4 papers) and Graphite, nuclear technology, radiation studies (4 papers). Samuel Thomas collaborates with scholars based in United States, Switzerland and France. Samuel Thomas's co-authors include Bruce W. Surber, Jon F. Denissen, Dale J. Kempf, Brian Grabowski, Gondi Kumar, John T. Uchic, Alex Buko, Ellen Roberts, Ye Yao and G. Richard Granneman and has published in prestigious journals such as IEEE Access, European Journal of Pharmacology and Pharmaceutical Research.

In The Last Decade

Samuel Thomas

11 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samuel Thomas United States	6	279	147	85	83	69	11	421
William D. Fiske United States	11	309 1.1×	209 1.4×	85 1.0×	83 1.0×	54 0.8×	17	544
Steve West United States	7	339 1.2×	195 1.3×	75 0.9×	71 0.9×	62 0.9×	9	408
Aurélie Fayet Switzerland	9	408 1.5×	254 1.7×	61 0.7×	111 1.3×	70 1.0×	11	552
John T. Uchic United States	9	214 0.8×	103 0.7×	69 0.8×	62 0.7×	86 1.2×	12	419
R Cvetković New Zealand	6	278 1.0×	85 0.6×	60 0.7×	46 0.6×	91 1.3×	10	543
Munehiro Yoshino Japan	6	240 0.9×	140 1.0×	52 0.6×	72 0.9×	39 0.6×	15	355
Keith Erdman United States	7	327 1.2×	234 1.6×	83 1.0×	111 1.3×	29 0.4×	9	504
D.M. Burger Netherlands	12	364 1.3×	193 1.3×	93 1.1×	106 1.3×	27 0.4×	27	461
Catherine Gillotin France	15	278 1.0×	171 1.2×	71 0.8×	86 1.0×	34 0.5×	26	616
Neil Buss Switzerland	13	375 1.3×	252 1.7×	71 0.8×	90 1.1×	98 1.4×	17	655

Countries citing papers authored by Samuel Thomas

Since Specialization

Citations

This map shows the geographic impact of Samuel Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Thomas more than expected).

Fields of papers citing papers by Samuel Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Thomas. The network helps show where Samuel Thomas may publish in the future.

Co-authorship network of co-authors of Samuel Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Thomas. A scholar is included among the top collaborators of Samuel Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Thomas. Samuel Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Menaa, N., et al.. (2021). Photons fluence to local skin Dose coefficients and benchmark with three Monte-Carlo codes. Application to the computation of radioactive material transport limits. Applied Radiation and Isotopes. 176. 109892–109892. 1 indexed citations

Menaa, N., et al.. (2021). Skin dose contamination conversion coefficients. Benchmark with three simulation codes. Journal of Radiological Protection. 42(1). 1 indexed citations

Menaa, N., et al.. (2021). Calculation and benchmark of fluence-to-local skin equivalent dose coefficients for neutrons with FLUKA, MCNP, and GEANT4 Monte-Carlo codes. Journal of Radiological Protection. 41(3). 564–578. 10 indexed citations

Thomas, Samuel, et al.. (2020). Computation of Radioactive Material Transport Limits Within A1/A2 Working Group at IAEA TRANSSC. IEEE Access. 8. 29040–29054. 2 indexed citations

Kumar, Gondi, John T. Uchic, Samuel Thomas, et al.. (2004). Metabolism and Disposition of the HIV-1 Protease Inhibitor Lopinavir (ABT-378) Given in Combination with Ritonavir in Rats, Dogs, and Humans. Pharmaceutical Research. 21(9). 1622–1630. 90 indexed citations

Kumar, Gondi, Ellen Roberts, Dean Hickman, et al.. (1999). Potent Inhibition of the Cytochrome P-450 3A-Mediated Human Liver Microsomal Metabolism of a Novel HIV Protease Inhibitor by Ritonavir: A Positive Drug-Drug Interaction. Drug Metabolism and Disposition. 27(8). 902–908. 133 indexed citations

Kumar, Gondi, Ronald Lee, David N. Whittern, et al.. (1999). In Vitro Metabolism of the HIV-1 Protease Inhibitor ABT-378: Species Comparison and Metabolite Identification. Drug Metabolism and Disposition. 27(1). 86–91. 51 indexed citations

Cain, John C., et al.. (1997). [3H]R-Terazosin binds selectively to α1-adrenoceptors over α2-adrenoceptors – comparison with racemic [3H]terazosin and [3H]prazosin. European Journal of Pharmacology. 327(1). 79–86. 13 indexed citations

Denissen, Jon F., Brian Grabowski, Alex Buko, et al.. (1997). Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans.. PubMed. 25(4). 489–501. 115 indexed citations

10.

Surber, Bruce W., Samuel Thomas, Andrew S. Tasker, et al.. (1994). [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors. European Journal of Pharmacology Molecular Pharmacology. 267(1). 49–54. 3 indexed citations

11.

Thomas, Ralph H., et al.. (1975). Population Exposure from High-energy Accelerators. Health Physics. 29(6). 853–860. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact